肿瘤学与转化医学（英文）Issue(1)：20-25,6.DOI:10.1007/s10330-015-0052-5
Advances in the management of acquired resistance to EGFR-TKI in non-small cell lung cancer
Advances in the management of acquired resistance to EGFR-TKI in non-small cell lung cancer
Fei Zhou 1Caicun Zhou1
作者信息
- 1. Department of Medical 0ncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China
- 折叠
摘要
关键词
non-smal Cell lung cancer (NSCLC)/epidermal growth factor receptor (EGFR)/targeted therapy/acquired resistanceKey words
non-smal Cell lung cancer (NSCLC)/epidermal growth factor receptor (EGFR)/targeted therapy/acquired resistance引用本文复制引用
Fei Zhou,Caicun Zhou..Advances in the management of acquired resistance to EGFR-TKI in non-small cell lung cancer[J].肿瘤学与转化医学（英文）,2015,(1):20-25,6.
